Filtered By:
Specialty: Research
Condition: Atrial Fibrillation
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 257 results found since Jan 2013.
Investigation on Imaging Features and Clinical Significance of Cardiac CT in Comprehensive Evaluation of Aortic Valve and Root before Percutaneous Aortic Valve Replacement
This study retrospectively includes patients with severe aortic stenosis who underwent TAVR with routine computed tomography. Based on CT images, the determination and grouping of bicuspid aortic valve and tricuspid aortic valve were completed. Thirteen cross-sectional levels of the aorta-iliac-femoral vascular access were completed. The results showed that 3 people had stroke (17.6%) and 5 people had myocardial infarction (29.4%) during the follow-up period. Atrial fibrillation occurred in 5 patients (29.4%), permanent pacemaker implantation was performed in 1 patient (5.9%), and acute kidney injury occurred in 7 patients...
Source: Biomed Res - September 30, 2022 Category: Research Authors: Xiong Tan Juan Peng Source Type: research
AI-guided screening uses ECG data to detect a hidden risk factor for stroke
An AI-guided targeted screening strategy is effective in detecting new cases of atrial fibrillation that would not have come to attention in routine clinical care. This strategy could reduce the number of undiagnosed cases of atrial fibrillation, and prevent stroke and death in millions of patients across the globe. ROCHESTER, Minn. — Researchers at Mayo Clinic used artificial intelligence (AI) to evaluate patients’ electrocardiograms (ECGs) in a targeted strategy to screen for atrial fibrillation, a…
Source: Mayo Clinic Research News - September 28, 2022 Category: Research Source Type: news
Payer Formulary exclusions of apixaban: how patients respond and potential implications
Curr Med Res Opin. 2022 Sep 26:1-10. doi: 10.1080/03007995.2022.2128189. Online ahead of print.ABSTRACTIn recent years, U.S. payers have increased usage of formulary exclusions as a means to help manage costs. Earlier this year, one of the largest pharmacy benefit managers in the country added Eliquis (apixaban), the most widely used anticoagulant, to its list of excluded medicines from its formulary, raising concerns by physicians and patients. In this commentary, we examine the potential impacts of formulary exclusion of a drug like apixaban-a treatment for patients with atrial fibrillation and venous thromboembolism to ...
Source: Current Medical Research and Opinion - September 27, 2022 Category: Research Authors: Steven Deitelzweig Emi Terasawa Amiee Kang Nipun Atreja Dionne M Hines Ahmed Noman Xuemei Luo Source Type: research
Anesthetic management using remimazolam in a patient with atrial flutter: a case report
Am J Transl Res. 2022 Aug 15;14(8):5754-5759. eCollection 2022.ABSTRACTRemimazolam is a new intravenously administered ultra-short-acting benzodiazepine used in anesthesia or sedation. Remimazolam offers several advantages over other short-acting sedatives, including an organ-independent metabolism and rapid and predictable onset and recovery. Furthermore, remimazolam shows less cardiovascular-inhibitory effects than other anesthetics. Atrial flutter is a form of cardiac arrhythmia that is associated with serious health-related outcomes and a substantial economic burden. Acute onset of atrial flutter can cause cardiac dysf...
Source: American Journal of Translational Research - September 15, 2022 Category: Research Authors: Joo Yong Lee Hyeon Tae Kim Yae Jee Kim Jin Sol Lee Jin Wook Park Young Duck Shin Source Type: research
